European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin...
European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention
About this item
Full title
Author / Creator
Publisher
Milan: Springer Milan
Journal title
Language
English
Formats
Publication information
Publisher
Milan: Springer Milan
Subjects
More information
Scope and Contents
Contents
Background and aim
Monoclonal antibodies acting on the calcitonin gene-related peptide or on its receptor are new drugs to prevent migraine. Four monoclonal antibodies have been developed: one targeting the calcitonin gene-related peptide receptor (erenumab) and three targeting the calcitonin gene-related peptide (eptinezumab, fremanezumab, and...
Alternative Titles
Full title
European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_111b558bacf04cce8945107f6ffbe9f1
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_111b558bacf04cce8945107f6ffbe9f1
Other Identifiers
ISSN
1129-2369,1129-2377
E-ISSN
1129-2377
DOI
10.1186/s10194-018-0955-y
